Innovation Pharmaceuticals Inc (IPIX)

[Scottwny]

Maybe it has something to do with Per Protocol vs. ITT. The only solution I can come up with using normal decimal rounding is 6 of 13 patients.

Or maybe something with the last sentence that is throwing me off:

IPIX: Among patients with the severest form of psoriasis in study, those having a baseline IGA score of 3 (“moderate”), the primary endpoint was met in 46% of patients who received 200 mg per day. These data were derived from analyses of all patients.